Lower levels of reimbursement in France and the pressure on doctors to cut costs has led to lower drug sales for the 23,000 registered pharmacies there. Since the start of 1994, health care spending growth has slowed considerably. The national French pharmacists' union, the UNPF, says sales have declined by an average of 3% in the first five months of this year.
The union adds that other factors are also causing concern, including increased competition from supermarkets and outlets specializing in over-the-counter pharmacy goods, the ending of wholesaler discounts and, above all, the application of the degressive margin mechanism. This mechanism operates on the basis that the higher the drug price the lower the pharmacy margin.
The pharmacy organizations claim that 1,000 pharmacies are now on the verge of bankruptcy and 3,000 have excessive debt levels. A recent report from Credit National says the prospects for pharmacies appears "compromised." New pay negotiations with the registered pharmacists' unions were announced in mid-May.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze